McGiven J A, Tucker J D, Perrett L L, Stack J A, Brew S D, MacMillan A P
Department of Bacterial Diseases, FAO/WHO Collaborating Centre for Reference and Research on Brucellosis, Veterinary Laboratories Agency, Woodham Lane, New Haw, Weybridge, Surrey, KT15 3NB, UK.
J Immunol Methods. 2003 Jul;278(1-2):171-8. doi: 10.1016/s0022-1759(03)00201-1.
The fluorescence polarisation assay (FPA) is a recently described test for the serological diagnosis of Brucella infection. It has many methodological advantages over older, more established tests and can be performed in a fraction of the time. To validate the FPA, serum samples from 146 confirmed (by culture) Brucella-infected cattle were tested in conjunction with serum samples from 1947 noninfected cattle. The competitive ELISA (cELISA) was validated using these positive reference samples and 1440 negative samples, while data for the indirect ELISA (iELISA) was generated from 6957 negative samples plus the positive sera. Published diagnostic specificity (DSp) data for the complement fixation test (CFT) and serum agglutination test (SAT) was used in conjunction with the test results on the positive sera to obtain diagnostic specificity plus diagnostic sensitivity (DSn). After selection of a cutoff for the FPA and cELISA, the diagnostic specificity and sensitivity total for each test were compared. The results, with 95% confidence intervals, were: FPA (195.7+/-2.79), iELISA (195.0+/-2.70), cELISA (194.9+/-3.48), CFT (191.7+/-4.45), and SAT (180.4+/-6.33). The data presented supports the use of the FPA in diagnosis of brucellosis and questions the use of the SAT and CFT for either screening or confirmatory testing.
荧光偏振测定法(FPA)是一种最近报道的用于布鲁氏菌感染血清学诊断的检测方法。与更成熟的旧检测方法相比,它具有许多方法学上的优势,并且可以在更短的时间内完成检测。为了验证FPA,对146头经培养确诊为布鲁氏菌感染的牛的血清样本以及1947头未感染牛的血清样本进行了检测。使用这些阳性参考样本和1440份阴性样本对竞争ELISA(cELISA)进行了验证,而间接ELISA(iELISA)的数据则来自6957份阴性样本和阳性血清。补体结合试验(CFT)和血清凝集试验(SAT)已发表的诊断特异性(DSp)数据与阳性血清的检测结果一起用于获得诊断特异性加诊断敏感性(DSn)。在为FPA和cELISA选择临界值后,比较了每个检测的诊断特异性和敏感性总和。结果及其95%置信区间为:FPA(195.7±2.79)、iELISA(195.0±2.70)、cELISA(194.9±3.48)、CFT(191.7±4.45)和SAT(180.4±6.33)。所呈现的数据支持使用FPA诊断布鲁氏菌病,并对将SAT和CFT用于筛查或确证检测提出质疑。